Home / Government / Central Government News Tools: Save | Print | E-mail | Most Read | Comment
Sales, use of post-surgical drug aprotinin suspended
Adjust font size:

The top drug watchdog on Monday suspended the sale and use of aprotinin, used to control post-surgical bleeding, after adverse reactions were reported abroad.

"According to statistics from the National Center for ADR [Adverse Drug Reaction] Monitoring, aprotinin injections could cause adverse reactions including allergy, allergic shock, palpitation, choking, breathing with difficulty, shivering, fever, sickness and vomiting," the State Food and Drug Administration (SFDA) said in a statement posted on its website.

No adverse reactions have been reported in China.

Aprotinin is used to reduce blood losses and the need for transfusions in patients undergoing a cardiopulmonary bypass in the course of coronary artery bypass graft surgery.

Following an overall safety evaluation, the SFDA concluded that the risks of the drug exceeded its benefits and that it should be taken off the market.

The decision followed the suspension last month of aprotinin-containing medicines for systemic use in the United States, Canada, Germany and Spain. Results from a randomized interim trial by the Ottawa Health Institute showed increased mortality for patients receiving aprotinin.

The German manufacturer, Bayer, subsequently decided to suspend the worldwide marketing of its aprotinin-containing medicinal products, Trasylol and Trasynin.

According to the SFDA, there were 20 enterprises in China producing aprotinin injections. The drug had not been imported and no injections from Bayer had been sold in China.

(Xinhua News Agency December 18, 2007)

Tools: Save | Print | E-mail | Most Read
Pet Name
China Archives
Related >>
- Penalty guidelines set for fake drugs
- Ensuring drug safety
- 300 drug and medical factories caught in raids
- China to sell quality anti-malaria drugs to Africa
- Pact on drugs, equipment safety inked
Most Viewed >>
Questions and Answers More
Q: What kind of law is there in place to protect pandas?
A: In order to put the protection of giant pandas and other wildlife under the law, the Chinese government put the protection of rare animals and plants into the Constitution.
Useful Info
- Who's Who in China's Leadership
- State Structure
- China's Political System
- China's Legislative System
- China's Judicial System
- Mapping out 11th Five-Year Guidelines
- Chinese Embassies
- International Department, Central Committee of CPC
- State Organs Work Committee of CPC
- United Front Work Department, Central Committee of CPC